Balyasny Asset Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,916
| Closed | -$66K | – | 1941 |
|
|
2025
Q1 | $66K | Sell |
18,916
-22,774
| -55% | -$79.5K | ﹤0.01% | 1929 |
|
|
2024
Q4 | $136K | Buy |
+41,690
| New | +$136K | ﹤0.01% | 1789 |
|
|
2023
Q1 | – | Sell |
-14,633
| Closed | -$34.1K | – | 2138 |
|
|
2022
Q4 | $34.1K | Buy |
14,633
+2,384
| +19% | +$5.56K | ﹤0.01% | 1964 |
|
|
2022
Q3 | $23K | Buy |
+12,249
| New | +$23K | ﹤0.01% | 2079 |
|
|
2021
Q2 | – | Sell |
-12,147
| Closed | -$40K | – | 1631 |
|
|
2021
Q1 | $40K | Buy |
+12,147
| New | +$40K | ﹤0.01% | 1504 |
|